The board of directors of AstraZeneca Pharma India Limited at its Meeting held on December 14, 2022, approved the Resignation of Mr. Gagandeep Singh Bedi (DIN: 07844333) from the Office of Managing Director of the Company with effect from the closing of business hours on December 31, 2022. Reason for Resignation: Consequent to transfer to a new position within AstraZeneca Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,566 INR | -0.88% |
|
-5.05% | +18.96% |
1st Jan change | Capi. | |
---|---|---|
+18.96% | 1.96B | |
+61.53% | 848B | |
+33.28% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+13.57% | 243B | |
+16.26% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022